Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis. Issue 5 (May 2022)
- Record Type:
- Journal Article
- Title:
- Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis. Issue 5 (May 2022)
- Main Title:
- Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis
- Authors:
- Sugumar, Kavin
Hurtado, Alex
Naik, Ilora
Hue, Jonathan J.
Rothermel, Luke D.
Ammori, John B.
Hardacre, Jeffrey M.
Winter, Jordan M.
Ocuin, Lee M. - Abstract:
- Abstract: Background: Irreversible electroporation (IRE) is used as a locoregional treatment modality for patients with locally advanced pancreatic cancer (LAPC), but is non-curative and is associated with postoperative morbidity and mortality. We performed a systematic review and meta-analysis comparing survival outcomes of multimodal therapy with or without IRE. Methods: Separate searches were performed for multimodal therapy + IRE and multimodal therapy alone given the lack of comparative literature using PubMed, SCOPUS, and Cochrane Library in 3/2021. We determined overall survival (OS) and progression-free survival (PFS) from diagnosis and time of IRE. Treatment-related morbidity and mortality was determined. Results: Of 585 published articles, 48 met inclusion criteria for IRE (n = 27) and without IRE (n = 21) with data for 1420 (IRE) and 1348 (without IRE) patients. The 6/12/24 months OS with IRE was 99%/84%/28%. The 6/12/24 months OS without IRE was 99%/80%/12%. At 12 months from IRE, OS was 55% and PFS was 12%. The mean major complication and 90-day mortality rates for IRE were 17.95% and 2.65%. Conclusion: Multimodal therapy alone is associated with similar OS to multimodal therapy + IRE in patients with LAPC. Most patients progress and nearly half die within 1 year of the IRE procedure. Given the lack of quality prospective data, IRE should remain experimental and be used with caution in LAPC.
- Is Part Of:
- HPB. Volume 24:Issue 5(2022)
- Journal:
- HPB
- Issue:
- Volume 24:Issue 5(2022)
- Issue Display:
- Volume 24, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 24
- Issue:
- 5
- Issue Sort Value:
- 2022-0024-0005-0000
- Page Start:
- 586
- Page End:
- 595
- Publication Date:
- 2022-05
- Subjects:
- Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005 - Journal URLs:
- https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1016/j.hpb.2021.12.014 ↗
- Languages:
- English
- ISSNs:
- 1365-182X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21568.xml